Where I see patients (3)
My reviews
Selected research
-
Corrigendum to "Cabozantinib Plus Nivolumab in Patients with Non-Clear Cell Renal Cell Carcinoma: Updated Results from a Phase II Trial" [Eur. Urol. 86(2) (2024) 90-94].
European urology
-
Accuracy, readability, and quality of websites about metastatic renal cell carcinoma treatment.
Urologic oncology
-
Lung sparing in MR-guided non-adaptive SBRT treatment of peripheral lung tumors.
Biomedical physics & engineering express
Clinical trials
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
The proportion of participants who have not demonstrated radiographic progression as defined by Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 or demonstrated clinical progression-free survival (PFS) at 12 month...
Recruiting
5.0